Redox dual-stimuli responsive drug delivery systems for improving tumor-targeting ability and reducing adverse side effects
Cancer is a big challenge that has plagued the human beings for ages and one of the most effective treatments is chemotherapy. However, the low tumor-targeting ability limits the wide clinical application of chemotherapy. The microenvironment plays a critical role in many aspects of tumor genesis. I...
Main Authors: | Ruirui Li, Feifei Peng, Jia Cai, Dandan Yang, Peng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | Asian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1818087619301199 |
Similar Items
-
Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis
by: Sabya Sachi Das, et al.
Published: (2020-06-01) -
Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting
by: Muhammad Abdur Rahim, et al.
Published: (2021-02-01) -
Lung Cancer Targeted Chemoradiotherapy via Dual-Stimuli Responsive Biodegradable Core-Shell Nanoparticles
by: Roshni Iyer, et al.
Published: (2022-07-01) -
Redox/pH-Responsive 2-in-1 Chimeric Nanoparticles for the Co-Delivery of Doxorubicin and siRNA
by: Hsi-Chin Wu, et al.
Published: (2021-12-01) -
Redox-Responsive Mesoporous Silica Nanoparticles for Cancer Treatment: Recent Updates
by: Miguel Gisbert-Garzarán, et al.
Published: (2021-08-01)